Efficacy and Safety of Sintilimab Combined With Nab-paclitaxel and Tegio (aTS) as First-line Treatment of Unresectable Locally Advanced, Recurrent or Metastatic Adenocarcinoma of Gastric and Gastroesophageal Junction，a Phase II Clinical Study
Clinical trial NCT06241469 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06241469
- Sponsor
- Wu Jun
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-03
- Primary completion
- 2026-08-02
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.